Lupin LimitedNSE: LUPIN

Lupin Limited Press Release Feb 09 2023

· Issued by Lupin Limited via NSE India

Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated February 09, 2023, titled "Lupin Receives Approval from U.S. FDA for Glycopyrrolate Injection, USP.".

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

In the deck

Earlier from Lupin

Later from Lupin

All Lupin news releases